The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serum biomarkers of inflammation (ferritin, IL-8, TNFR1) and outcomes in BOLERO-2, a phase III trial of HR+/HER2- metastatic breast cancer treated with everolimus (mTOR inhibitor).
 
Suhail M. Ali
No Relationships to Disclose
 
Albert Reising
Employment - Novartis; Novartis
Stock and Other Ownership Interests - Novartis
 
Kim Leitzel
No Relationships to Disclose
 
Joseph J. Drabick
Consulting or Advisory Role - Sanofi/Aventis
 
Cristina I. Truica
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Novartis; Puma Biotechnology
Consulting or Advisory Role - Novartis; Puma Biotechnology
Speakers' Bureau - Puma Biotechnology
Research Funding - Novartis
Travel, Accommodations, Expenses - Novartis; Puma Biotechnology
 
Monali K. Vasekar
No Relationships to Disclose
 
Harry Menon
No Relationships to Disclose
 
Vinod Nagabhairu
No Relationships to Disclose
 
Hyma Vani Polimera
No Relationships to Disclose
 
Neha Pancholy
No Relationships to Disclose
 
Prashanth Reddy Moku
No Relationships to Disclose
 
Ashok Maddukuri
No Relationships to Disclose
 
Herbert Schmid
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Wei He
No Relationships to Disclose
 
John Millholland
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Meredith Lavin
No Relationships to Disclose
 
Scott J. Hofsess
No Relationships to Disclose
 
Robert William Sweetman
No Relationships to Disclose
 
Gabriel N. Hortobagyi
Consulting or Advisory Role - Agendia; Novartis; Peregrine Pharmaceuticals
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Allan Lipton
No Relationships to Disclose